BR112019004936A2 - extrato de pó vegetal, e purificador de água - Google Patents
extrato de pó vegetal, e purificador de águaInfo
- Publication number
- BR112019004936A2 BR112019004936A2 BR112019004936A BR112019004936A BR112019004936A2 BR 112019004936 A2 BR112019004936 A2 BR 112019004936A2 BR 112019004936 A BR112019004936 A BR 112019004936A BR 112019004936 A BR112019004936 A BR 112019004936A BR 112019004936 A2 BR112019004936 A2 BR 112019004936A2
- Authority
- BR
- Brazil
- Prior art keywords
- component
- exhibits
- measurement
- fractional
- extract
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/52—Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities
- C02F1/54—Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities using organic material
- C02F1/56—Macromolecular compounds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D21/00—Separation of suspended solid particles from liquids by sedimentation
- B01D21/01—Separation of suspended solid particles from liquids by sedimentation using flocculating agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/28—Treatment of water, waste water, or sewage by sorption
- C02F1/286—Treatment of water, waste water, or sewage by sorption using natural organic sorbents or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/52—Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities
- C02F1/5263—Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities using natural chemical compounds
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/52—Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities
- C02F1/5272—Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities using specific organic precipitants
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/52—Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities
- C02F1/54—Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities using organic material
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/58—Treatment of water, waste water, or sewage by removing specified dissolved compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6927—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
- A61K47/6929—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle
- A61K47/6931—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle the material constituting the nanoparticle being a polymer
- A61K47/6939—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle the material constituting the nanoparticle being a polymer the polymer being a polysaccharide, e.g. starch, chitosan, chitin, cellulose or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
- A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
- A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
- A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
- A61K49/1851—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule
- A61K49/1863—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being a polysaccharide or derivative thereof, e.g. chitosan, chitin, cellulose, pectin, starch
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/52—Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities
- C02F1/5236—Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities using inorganic agents
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2101/00—Nature of the contaminant
- C02F2101/10—Inorganic compounds
- C02F2101/103—Arsenic compounds
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2101/00—Nature of the contaminant
- C02F2101/10—Inorganic compounds
- C02F2101/12—Halogens or halogen-containing compounds
- C02F2101/14—Fluorine or fluorine-containing compounds
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2101/00—Nature of the contaminant
- C02F2101/10—Inorganic compounds
- C02F2101/20—Heavy metals or heavy metal compounds
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2101/00—Nature of the contaminant
- C02F2101/10—Inorganic compounds
- C02F2101/20—Heavy metals or heavy metal compounds
- C02F2101/203—Iron or iron compound
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2101/00—Nature of the contaminant
- C02F2101/10—Inorganic compounds
- C02F2101/20—Heavy metals or heavy metal compounds
- C02F2101/22—Chromium or chromium compounds, e.g. chromates
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hydrology & Water Resources (AREA)
- Environmental & Geological Engineering (AREA)
- Water Supply & Treatment (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Separation Of Suspended Particles By Flocculating Agents (AREA)
- Removal Of Specific Substances (AREA)
- Water Treatment By Sorption (AREA)
- Peptides Or Proteins (AREA)
Abstract
a presente invenção fornece um extrato, que é um componente fracionado 1 de um extrato aquoso de um pó vegetal, em que o componente fracionado 1 é um componente fracionado com um peso molecular de fracionamento igual ou superior a 12.000, em que um componente não dissolvido em etanol do componente fracionado 1 exibe um pico atribuído ao ácido carboxílico em uma medição de espectroscopia de infravermelho por transformada de fourier (ft-ir) e exibe um pico atribuído à celulose em uma medição de cromatografia gasosa acoplada ao espectro de massas (gc-ms), e em que um componente dissolvido em etanol do componente fracionado 1 exibe um pico atribuído ao ácido carboxílico na medição de ft-ir e exibe um pico atribuído a uma proteína vegetal na medição de gc-ms, e um agente purificador de água contendo o extrato.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016181619 | 2016-09-16 | ||
JP2017174021A JP7131894B2 (ja) | 2016-09-16 | 2017-09-11 | 抽出物の製造方法、抽出物、水浄化剤、及び排水処理方法 |
PCT/JP2017/032941 WO2018051992A1 (ja) | 2016-09-16 | 2017-09-12 | 植物粉末の抽出物、及び水浄化剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112019004936A2 true BR112019004936A2 (pt) | 2019-06-18 |
Family
ID=61765750
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112019004936A BR112019004936A2 (pt) | 2016-09-16 | 2017-09-12 | extrato de pó vegetal, e purificador de água |
Country Status (7)
Country | Link |
---|---|
US (2) | US20190256387A1 (pt) |
EP (1) | EP3513857B1 (pt) |
JP (1) | JP7131894B2 (pt) |
KR (1) | KR102438091B1 (pt) |
BR (1) | BR112019004936A2 (pt) |
RU (1) | RU2019110785A (pt) |
TW (1) | TWI734834B (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113233564B (zh) | 2016-09-16 | 2023-08-08 | 迪睿合株式会社 | 植物粉末的提取物、及水净化剂 |
JP6722807B1 (ja) * | 2019-05-31 | 2020-07-15 | デクセリアルズ株式会社 | 水処理剤及びその製造方法、並びに水処理方法 |
WO2022070745A1 (ja) * | 2020-10-01 | 2022-04-07 | デクセリアルズ株式会社 | 有機凝結剤及びその製造方法、並びに水浄化剤及びその製造方法 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0341014A (ja) * | 1989-07-07 | 1991-02-21 | Ichimaru Pharcos Co Ltd | モロヘイヤ抽出物含有化粧料 |
JPH0769910A (ja) * | 1993-09-01 | 1995-03-14 | Otsuka Pharmaceut Co Ltd | 脂質代謝改善及び血糖上昇抑制組成物 |
JPH0770208A (ja) * | 1993-09-07 | 1995-03-14 | Kyodo Nyugyo Kk | モロヘイヤ粘性多糖体の製造法 |
KR19980081423A (ko) * | 1997-04-16 | 1998-11-25 | 이데이노부유끼 | 고분자 응집제, 이 응집제의 제조방법 및 이 응집제를 이용한수처리 방법 |
JP3049279B2 (ja) | 1997-08-19 | 2000-06-05 | 工業技術院長 | キトサン及びその製造方法と、高分子凝集剤 |
JP3876497B2 (ja) * | 1997-10-09 | 2007-01-31 | ソニー株式会社 | 凝集剤及びこれを用いた凝集方法 |
JP2000140509A (ja) | 1998-11-16 | 2000-05-23 | Kansai Kako Kk | 新規な凝集剤とそれを用いる汚泥処理方法 |
US20070112183A1 (en) | 2003-05-07 | 2007-05-17 | Research Institute For Production Development | Chitin oligomer composition and/or chitosan oligomer composition and processes for preparation thereof |
JPWO2004100969A1 (ja) | 2003-05-19 | 2006-07-13 | タカラバイオ株式会社 | 治療剤 |
JP2008126168A (ja) | 2006-11-22 | 2008-06-05 | Fuji Eng Kk | 廃水の凝集沈殿処理方法 |
JP5640419B2 (ja) | 2010-03-24 | 2014-12-17 | ソニー株式会社 | 排水中の重金属イオンの除去方法 |
JP2011194385A (ja) | 2010-03-24 | 2011-10-06 | Sony Corp | 陽イオン交換体、及び排水中の重金属イオンの除去方法 |
CN102583681B (zh) * | 2011-01-14 | 2014-07-02 | 索尼公司 | 植物来源的凝聚剂、凝聚剂混合物、凝聚方法以及制备植物来源的凝聚剂的方法 |
CN102247814A (zh) | 2011-05-17 | 2011-11-23 | 中国农业科学院麻类研究所 | 用于重金属废水处理的生物质吸附剂及重金属废水处理方法 |
GB201116050D0 (en) | 2011-09-16 | 2011-11-02 | Ntnu Technology Transfer As | Ionic gel |
CN102432692A (zh) | 2011-12-27 | 2012-05-02 | 西华师范大学 | 华美牛肝菌多糖 |
JP2014008428A (ja) | 2012-06-28 | 2014-01-20 | Sony Corp | 凝集剤混合物及び凝集方法 |
PE20160473A1 (es) | 2013-05-29 | 2016-05-22 | Aguas De Manizales S A E S P | Composiciones para tratamiento de aguas y metodos para uso de las mismas |
CN103641936B (zh) | 2013-12-09 | 2016-03-23 | 吴彪 | 一种采用超滤和纳滤制备水溶性壳寡糖的方法 |
JP6301802B2 (ja) | 2014-10-03 | 2018-03-28 | デクセリアルズ株式会社 | 水浄化剤、及び水浄化方法 |
CN104562632B (zh) * | 2015-01-12 | 2016-08-24 | 哈尔滨工业大学 | 一种微波快速改性黄麻制备重金属离子交换纤维的方法及应用 |
JP6695662B2 (ja) | 2015-02-12 | 2020-05-20 | 国立大学法人京都大学 | 多糖類のナノファイバー、分散媒及びモノマーを含む分散体、並びにその分散体から得られる樹脂組成物 |
-
2017
- 2017-09-11 JP JP2017174021A patent/JP7131894B2/ja active Active
- 2017-09-12 BR BR112019004936A patent/BR112019004936A2/pt not_active IP Right Cessation
- 2017-09-12 EP EP17850893.3A patent/EP3513857B1/en active Active
- 2017-09-12 RU RU2019110785A patent/RU2019110785A/ru not_active Application Discontinuation
- 2017-09-12 KR KR1020197010107A patent/KR102438091B1/ko active IP Right Grant
- 2017-09-12 US US16/333,440 patent/US20190256387A1/en not_active Abandoned
- 2017-09-15 TW TW106131858A patent/TWI734834B/zh active
-
2021
- 2021-08-24 US US17/410,356 patent/US11866354B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
TW201813933A (zh) | 2018-04-16 |
TWI734834B (zh) | 2021-08-01 |
US20190256387A1 (en) | 2019-08-22 |
JP2018047454A (ja) | 2018-03-29 |
KR102438091B1 (ko) | 2022-08-31 |
US11866354B2 (en) | 2024-01-09 |
RU2019110785A (ru) | 2020-10-16 |
KR20190046992A (ko) | 2019-05-07 |
EP3513857A1 (en) | 2019-07-24 |
US20210380444A1 (en) | 2021-12-09 |
EP3513857A4 (en) | 2020-06-03 |
EP3513857B1 (en) | 2021-05-26 |
JP7131894B2 (ja) | 2022-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112018000632A2 (pt) | moléculas de anticorpo que ligam a cd79 | |
BR112018016307A2 (pt) | usos de composição e de produto, método de combate a maus odores e composição | |
BR112015001690A2 (pt) | mutações associadas com a resistência a inibidores da tirosina quinase de bruton (btk) | |
BR112016023630A2 (pt) | dispersão aquosa e composição de revestimento compreendendo a mesma | |
BR112019004936A2 (pt) | extrato de pó vegetal, e purificador de água | |
BR112012023283A2 (pt) | cosmético de cabelo | |
BR112016014969A2 (pt) | polipeptídeo, formulação farmacêutica e uso de um polipeptídeo | |
BR112016010422A8 (pt) | suplemento dietético, e uso de uma composição | |
BR112017000671A2 (pt) | moléculas com especificidade para cd79 e cd22 | |
BR112017017217A2 (pt) | ?composição que compreende ramnolipídeo e siloxano? | |
BR112017002053A2 (pt) | composto de acordo com a fórmula (i), composição farmacêutica, e usos de um composto | |
BRPI0905733B8 (pt) | composição, formulação farmacêutica, método para a produção de uma composição farmacêutica e uso de uma formulação farmacêutica | |
BR112018010271A2 (pt) | material cristalino sintético emm-28, sua preparação e uso | |
BR112017011387A2 (pt) | uso de compostos, e, composição cosmética. | |
WO2015177175A3 (en) | Novel specific-binding polypeptides and uses thereof | |
BRPI0916069C1 (pt) | composto, usos de um composto, composição farmacêutica, composição cosmética e usos cosméticos de uma composição | |
BR112015017251A8 (pt) | composições farmacêuticas compreendendo doadores de nitroxil, misturas e usos das referidas composições farmacêuticas | |
BR112013016590A2 (pt) | uso de estabilizantes de glutamina | |
BR112018006368A2 (pt) | composição para desempenho melhorado | |
BR112018068684A2 (pt) | uso de resinas modificadas com ácidos graxos para conferir propriedade antidedadas a uma folha de vidro | |
BR112018007635A2 (pt) | ?composição cosmética? | |
BR112015023209A2 (pt) | novos medicamentos compreendendo uma composição de anticorpo enrriquecida com uma carga principal de isoforma | |
BR112015019873A2 (pt) | inibidores macrocíclicos da lrrk2 cinase | |
BR112017000068A2 (pt) | composição eliminadora de maus odores e produto final | |
BR112019007744A2 (pt) | composição de revestimento aquosa, e, métodos de preparação da composição de revestimento aquosa e de concessão de estabilidade de congelamento e descongelamento a um polímero de emulsão acrílica. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 3A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2595 DE 29-09-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
B350 | Update of information on the portal [chapter 15.35 patent gazette] |